Are you looking for the fountain of youth? So is GlaxoSmithKline, and the pharmaceutical company is betting that it has found it — in red wine no less. Researchers have found a compound in red wine that slows the aging process, possibly prolonging life. American biotechnology company Sirtris discovered the compound, but Glaxo wants to own it and plans to buy the pharmaceutical start up for $720 million in cash. The company is gambling that this compound really works and hopes to reap the profits on many types of antiaging products.
Dr. David Sinclair of Harvard Medical School isolated the longevity compound resveratrol when experimenting with yeast. While helping yeast live longer may not seem that exciting, that same compound also countered the effects of a high-fat diet in mice and lengthened their little mouse life spans. Drugs modeled after this compound might help safely treat many deadly diseases that shorten our lives. So far, preliminary tests have shown the compound could lower blood sugar for people with diabetes. Sirtris hopes to develop compounds that have even stronger effects on slowing aging. Pretty cool, huh? Scientists are not encouraging us to drink more red wine, but this seems like pretty great reason to drink a glass tonight — just one glass, of course.